ACTH-producing pituitary gland carcinoma
disease diseaseOn this page
Also known as ACTH producing pituitary gland carcinomamalignant ACTH producing neoplasm of pituitarymalignant ACTH producing neoplasm of pituitary glandmalignant ACTH producing neoplasm of the pituitarymalignant ACTH producing neoplasm of the pituitary glandmalignant ACTH producing pituitary gland neoplasmmalignant ACTH producing pituitary gland tumormalignant ACTH producing pituitary gland tumourmalignant ACTH producing pituitary neoplasmmalignant ACTH producing pituitary tumormalignant ACTH producing pituitary tumourmalignant ACTH producing tumor of pituitarymalignant ACTH producing tumor of pituitary glandmalignant ACTH producing tumor of the pituitarymalignant ACTH producing tumor of the pituitary glandmalignant ACTH producing tumour of pituitarymalignant ACTH producing tumour of pituitary glandmalignant ACTH producing tumour of the pituitarymalignant ACTH producing tumour of the pituitary glandmalignant ACTH secreting neoplasm of pituitary
Summary
ACTH-producing pituitary gland carcinoma (MONDO:0006069) is a cancer. A subtype of pituitary adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | ACTH-producing pituitary gland carcinoma |
| Mondo ID | MONDO:0006069 |
| EFO | EFO:1000067 |
| DOID | DOID:6276 |
| NCIT | C5964 |
| UMLS | C1334556 |
| MedGen | 233657 |
| GARD | 0024281 |
| Anatomy (UBERON) | UBERON:0000007 |
| Is cancer (heuristic) | yes |
Also known as: ACTH producing pituitary gland carcinoma · malignant ACTH producing neoplasm of pituitary · malignant ACTH producing neoplasm of pituitary gland · malignant ACTH producing neoplasm of the pituitary · malignant ACTH producing neoplasm of the pituitary gland · malignant ACTH producing pituitary gland neoplasm · malignant ACTH producing pituitary gland tumor · malignant ACTH producing pituitary gland tumour · malignant ACTH producing pituitary neoplasm · malignant ACTH producing pituitary tumor · malignant ACTH producing pituitary tumour · malignant ACTH producing tumor of pituitary · malignant ACTH producing tumor of pituitary gland · malignant ACTH producing tumor of the pituitary · malignant ACTH producing tumor of the pituitary gland · malignant ACTH producing tumour of pituitary · malignant ACTH producing tumour of pituitary gland · malignant ACTH producing tumour of the pituitary · malignant ACTH producing tumour of the pituitary gland · malignant ACTH secreting neoplasm of pituitary (+47 more)
Disease family
This is a subtype of pituitary adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › head and neck carcinoma › pituitary adenocarcinoma › ACTH-producing pituitary gland carcinoma
Related subtypes (2): pituitary gland basophilic carcinoma, prolactin-producing pituitary gland carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.